GNRH1 and hepatotoxicity: Our results are in contradiction with another phase 1 study where abiraterone acetate plus prednisone was combined with LH-RH agonists and prostate and pelvic lymphnodes radiotherapy that showed that only 9% of patients presented grade 3 liver toxicity [19].